Khan, N. et al. 2025. Prospective Evaluation of Atrial Fibrillation Risk in Type 2 Diabetes Comparing SGLT-2 Inhibitors and DPP-4 Inhibitors. Indus Journal of Bioscience Research. 3, 3 (Mar. 2025), 69–75. DOI:https://doi.org/10.70749/ijbr.v3i3.797.